Lund A M, Müller J, Skovby F
Department of Clinical Genetics, Rigshospitalet 4062, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
Arch Dis Child. 1999 Jun;80(6):524-8. doi: 10.1136/adc.80.6.524.
Standing height, sitting height, armspan, subischial leg length, head circumference, and growth hormone-insulin-like growth factor I (IGF-I) axis were determined in 86 patients with osteogenesis imperfecta. The aim of this study was to determine standing height and body proportions and their variability among osteogenesis imperfecta types and collagen defects. Mean standing height was reduced in all groups of patients, to the greatest extent and variability in osteogenesis imperfecta type III/IV and in those with qualitative collagen defects. The mean standing height of patients with osteogenesis imperfecta was lower than that of their unaffected first degree family members. Truncal height of patients with osteogenesis imperfecta was reduced; head size was increased, and this was more pronounced in patients with osteogenesis imperfecta type III/IV and qualitative collagen defects than in patients with osteogenesis imperfecta type I and quantitative collagen defects. Mean concentrations of IGF-I and IGF binding protein 3 (IGFBP-3) were low, but most values were within age specific reference values. The reduction of standing height appears to correlate with osteogenesis imperfecta type and the type of collagen defect. A relatively short trunk is typical and head circumference and body length are disproportionate.
对86例成骨不全患者测定了身高、坐高、臂展、坐骨下腿长、头围以及生长激素-胰岛素样生长因子I(IGF-I)轴。本研究的目的是确定成骨不全各类型及胶原缺陷患者的身高和身体比例及其变异性。所有患者组的平均身高均降低,其中III/IV型成骨不全患者以及存在胶原质性质缺陷的患者身高降低程度最大且变异性最高。成骨不全患者的平均身高低于其未受影响的一级亲属。成骨不全患者的躯干高度降低;头部尺寸增大,且III/IV型成骨不全患者和存在胶原质性质缺陷的患者比I型成骨不全患者和存在胶原定量缺陷的患者更为明显。IGF-I和IGF结合蛋白3(IGFBP-3)的平均浓度较低,但大多数值在年龄特异性参考值范围内。身高降低似乎与成骨不全类型和胶原缺陷类型相关。典型表现为躯干相对较短,头围与身长不成比例。